Is TVRD research on Rallies investment advice?

No. Rallies provides research, data, and educational context for TVRD. It does not provide personalized investment advice.

TVRD (Tvardi Therapeutics, Inc. Common Stock) Stock Analysis - Financials

Tvardi Therapeutics, Inc. Common Stock (TVRD) is a publicly traded Healthcare sector company. As of October 14, 2026, TVRD trades at $1.02 with a market cap of $14.14M and a P/E ratio of -0.44. TVRD moved +0.00% today. Year to date, TVRD is -74.51%; over the trailing twelve months it is -84.45%. Its 52-week range spans $0.93 to $43.65. Analyst consensus is buy with an average price target of $8.20. Rallies surfaces TVRD's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.

What are TVRD's key financials?

TVRD financials on Rallies include revenue, net income, EPS, valuation metrics, market cap, price history, and balance sheet context. TVRD recently traded at $1.02. Market cap is $14.14M. P/E ratio is -0.44. Revenue is $0.

TVRD Key Metrics

Key financial metrics for TVRD
Metric	Value
Price	$1.02
Market Cap	$14.14M
P/E Ratio	-0.44
EPS	$-2.46
Dividend Yield	0.00%
52-Week High	$43.65
52-Week Low	$0.93
Volume	4.23K
Avg Volume	0
Revenue (TTM)	$0
Net Income	$-18.21M
Gross Margin	0.00%

TVRD Analyst Consensus

6 analysts cover TVRD: 0 strong buy, 4 buy, 1 hold, 1 sell, 0 strong sell. Consensus rating is buy. Average price target: $8.20.

Common questions about TVRD

What are TVRD's key financials?: TVRD financials on Rallies include revenue, net income, EPS, valuation metrics, market cap, price history, and balance sheet context. TVRD recently traded at $1.02. Market cap is $14.14M. P/E ratio is -0.44. Revenue is $0.
Is TVRD research on Rallies investment advice?: No. Rallies provides research, data, and educational context for TVRD. It does not provide personalized investment advice.